![](https://investorshub.advfn.com/uicon/529502.png?cb=1651683647)
Wednesday, October 12, 2022 5:38:29 PM
The patents to something that hasn't been tested, and most likely never will, will still be worthless even if other companies have success with a similar tech.
It would be one thing if Koos actually had a team and funding to get it into clinical trials but we all know that's not going to happen.
So, the wishful thinking of "because that company has it and is successful mean our company will prosper too" just won't bear out just like the thought of $RGBP getting current will make the stock take off like Enzolytics did. That was another harebrained prediction I thoroughly destroyed.
FACTS are stubborn things
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM